Lourdes Felix
Chief Executive Officer bei BIOCORRX INC.
Vermögen: 123 619 $ am 31.03.2024
Profil
Lourdes Felix is the founder of BioCorRx Pharmaceuticals, Inc. She currently holds multiple positions as a Director, CFO, Chief Executive & Operating Officer at BioCorRx, Inc. Additionally, she serves as an Independent Director at Siyata Mobile, Inc., Lichen China Ltd., Vocodia Holdings Corp., Avalon GloboCare Corp., and La Rosa Holdings Corp.
Ms. Felix completed her undergraduate degree in 2005 from the University of Phoenix and holds an MBA from D'Amore-Mckim School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOCORRX, INC.
0,93% | 28.03.2024 | 80 395 ( 0,93% ) | 71 954 $ | 31.03.2024 |
BIOCORRX, INC.
25,00% | 25.03.2024 | 40 000 ( 25,00% ) | 35 800 $ | 31.03.2024 |
BIOCORRX, INC.
12,50% | 25.03.2024 | 10 000 ( 12,50% ) | 8 950 $ | 31.03.2024 |
Vocodia Holdings Corp.
0,06% | 14.02.2024 | 5 000 ( 0,06% ) | 3 990 $ | 31.03.2024 |
| 04.04.2024 | 2 500 ( 0,01% ) | 2 925 $ | 31.03.2024 | |
AVALON GLOBOCARE CORP.
-.--% | 29.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Lourdes Felix
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCORRX INC. | Chief Executive Officer | 09.11.2020 |
| SIYATA MOBILE INC. | Director/Board Member | 29.10.2021 |
| LICHEN CHINA LIMITED | Director/Board Member | - |
| AVALON GLOBOCARE CORP. | Director/Board Member | 09.01.2023 |
| LA ROSA HOLDINGS CORP. | Director/Board Member | 17.04.2024 |
BioCorRx Pharmaceuticals, Inc.
 BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The private company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Founder | - |
| Vocodia Holdings Corp. | Director/Board Member | 22.02.2024 |
Ausbildung von Lourdes Felix
| University of Phoenix | Undergraduate Degree |
| D'Amore-Mckim School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BIOCORRX INC. | Health Services |
| AVALON GLOBOCARE CORP. | Health Technology |
| SIYATA MOBILE INC. | Electronic Technology |
| LICHEN CHINA LIMITED | Commercial Services |
| LA ROSA HOLDINGS CORP. | Finance |
| Private Unternehmen | 2 |
|---|---|
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The private company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
| Vocodia Holdings Corp. |
